Dentsply Sirona has unveiled an enhanced line of Symbios Allograft regenerative solutions designed to support a range of dental surgery and implant needs. This advanced line promotes bone formation, volume, and stability, aiming for predictable, long-term outcomes in bone regeneration.
The updated Symbios Allograft portfolio includes an expanded selection of granule allografts, versatile putty products, and Symbios PerioDerm—a specially designed acellular dermal matrix for soft-tissue applications. New offerings within the line feature both mineralized and demineralized allografts, as well as mixtures of the two, providing options that accommodate a wide variety of surgical preferences and clinical needs. Symbios Allografts are available in different granule sizes, allowing clinicians to select the optimal product for specific bone regeneration requirements.
Quality and safety are central to the Symbios Allograft line, with rigorous donor screening, disinfection, cleaning, preservation, and inspection protocols. Each product undergoes minimal manipulation, preserving tissue integrity while meeting the highest regulatory standards for safety and performance. This meticulous approach ensures that the allografts offer consistent, reliable outcomes, making them a trusted choice for dentists and oral surgeons involved in implantology and other regenerative procedures.
With this expanded line, Dentsply Sirona continues its commitment to innovation in dental care by providing solutions that enhance treatment results and improve patient outcomes. For more details, visit www.dentsplysirona.com or call 844.848.0137.